Russell Golson

We are committed to rewrite the data usage in early phase drug discoveries to rapidly meet todays unmet medical needs with greater certainty. Our cutting-edge software solution contextualizes Multiomics data to significantly lower the risks of key decisions on targets and diseases. With 80% of data context often overlooked, we harness Multiomics data to significantly de-risk research and enhance decision-making on disease markers, targets, and target-indication fits before entering clinical phases. Our Cellmap technology offers unmatched flexibility, being fluent across all biological data types, and streamlines research and insights to advance therapeutic strategies. By rapidly unlocking both private and public data, we break down traditional barriers to data contextualization, speeding up outcomes and deepening therapeutic understanding. knowing01 is more than a software; we are a strategic partner to rewrite your R&D data-to-outcome process. Together we will overcome tomorrows medical challenges. Better research = Better health Follow us. Join us on our journey. --- Under the hood-technologies – Our technology ranges from knowledge graphs, machine learning (ML) and artificial intelligence (AI). Our core technology effortless establishes billions of links in Big Data supporting the step getting from information to insight. --- Behind the scenes – knowing01s founding team combines a strong vision with proven expertise in research, deep tech, software and commercial experience. We commercialise IP from Helmholtz Munich, Germany.

We are committed to rewrite the data usage in early phase drug discoveries to rapidly meet todays unmet medical needs with greater certainty. Our cutting-edge software solution contextualizes Multiomics data to significantly lower the risks of key decisions on targets and diseases. With 80% of data context often overlooked, we harness Multiomics data to significantly de-risk research and enhance decision-making on disease markers, targets, and target-indication fits before entering clinical phases. Our Cellmap technology offers unmatched flexibility, being fluent across all biological data types, and streamlines research and insights to advance therapeutic strategies. By rapidly unlocking both private and public data, we break down traditional barriers to data contextualization, speeding up outcomes and deepening therapeutic understanding. knowing01 is more than a software; we are a strategic partner to rewrite your R&D data-to-outcome process. Together we will overcome tomorrows medical challenges. Better research = Better health Follow us. Join us on our journey. --- Under the hood-technologies – Our technology ranges from knowledge graphs, machine learning (ML) and artificial intelligence (AI). Our core technology effortless establishes billions of links in Big Data supporting the step getting from information to insight. --- Behind the scenes – knowing01s founding team combines a strong vision with proven expertise in research, deep tech, software and commercial experience. We commercialise IP from Helmholtz Munich, Germany.